Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.630
-0.040 (-1.50%)
At close: Oct 17, 2025, 4:00 PM EDT
2.621
-0.009 (-0.33%)
After-hours: Oct 17, 2025, 7:57 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $244.91 million as of October 17, 2025. Its market cap has increased by 52.27% in one year.
Market Cap
244.91M
Enterprise Value
86.82M
1-Year Change
52.27%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $244.91M, a decrease of -72.43%. That is a compound annual growth rate of -26.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 244.91M | 70.10% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.17B |
| Johnson & Johnson | 462.89B |
| AbbVie | 400.41B |
| UnitedHealth Group | 322.50B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 221.04B |